CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 shares for $175

• CTT Pharmaceutical CEO Ryan Khouri bought 3,500 CTTH shares at $0.05 each.
• Directly held stake rose to 9,400,556 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001035422-26-000011), on September 10, 2026, and is solely responsible for the information contained therein.